The Suncoast News - Jan. 20
FCA is a partner of the Moffitt Cancer Center.
Artist of the Day: Hannah's Whirl
TBT - Jan. 20
Arnone and Wingard have also both worked as medical professionals at Moffitt Cancer Center.
'Bodies Of Courage' blazes a path for cancer survivors
Tampa Bay Times - Jan. 20
On Tuesday, the work of artist Lisa Scholder will be on display at "Bodies Of Courage," an exhibit at H. Lee Moffitt Cancer Center's new satellite location at International Plaza that will showcase the photos and highlight the importance art can play in medicine.
Tampa area event listings: Chris Matthews book signing at Inkwood Books Jan. 21
Tampa Bay Times - Jan. 19
Seminar for brain tumors:Moffitt Cancer Center and the Florida Brain Tumor Association will present the "Together in Hope" seminar, from 7:30 a.m. to 5:30 p.m. Saturday at 12902 Magnolia Drive.
Gaspar's Named ‘Business of the Year'
Temple Terrace Patch - Jan. 19
The chamber also presented a special recognition award to H. Lee Moffitt Cancer Center and Research Institute for its service to the community.
Vemurafenib Treatment Triggers Squamous Cell Skin Cancers in Presence of Pre-existing RAS Mutations; MEK Inhibitor Combination Mitigates the Problem
Oncology Times - Jan. 19
The newly reported study, which was funded by Roche, the makers of vemurafenib, is important because they explain at a molecular level what was being seen in the clinic, according to Jeff Weber, MD, PhD, Director of the Donald A. Adam Comprehensive Melanoma Research Center at Moffitt Cancer Center in Tampa.
Local Cancer Event and Finance
Senior Voice America - Jan. 18
Interview is from 23:49 to 34:00
Peggie Sherry discusses the Bodies of Courage event Jan. 24 at Moffitt at International Plaza.
Rally At The Capitol For Cancer Funding
WCTV - Jan. 18
"We rode 340 miles from the front steps of Moffitt Cancer Center in Tampa to the front steps of the Capitol today just to kind-of create some buzz and get people out here," said Richard Spayde, one of the founders of Cure on Wheels.
Benefit carwash to help Pasco mother of four with rare cancer
Tampa Bay Times - Jan. 18
Surgeons at H. Lee Moffitt Cancer Center and Research Institute in Tampa removed the upper lobe of her right lung and portions of the left.
Cancer research topic at Rotary
The Tampa Tribune - Jan. 17
James J. Mulé executive vice president and associate center director for translational research, Moffitt Cancer Center, will speak when the Rotary Club of New Tampa meets Friday.
Moffitt's Annual Biotech Conference Feb. 6th, Tampa
83 Degrees - Jan. 17
Innovators, investors and entrepreneurs are encouraged to save the date Feb. 6th as the Moffitt Cancer Center will host its annual Business of Biotech conference.
Malignancy-risk gene signature developed for early-stage NSCLC
HemOnc Today - Jan. 16
Examining a malignancy-risk gene signature derived from a comparison of normal and malignant breast tissues, Dung-Tsa Chen, PhD, and colleagues from the Moffitt Cancer Center in Tampa, Fla., determined that the signature included genes involved in proliferation (56 of the 94 malignancy-risk genes, 59.6%) and with the loss of cell cycle control in the earliest stages of general tumor development.
Tampa Must Change Its 'Economic DNA,' Mayor Says
New Tampa Patch - Jan. 13
Buckhorn said cutting-edge endeavors at the Moffitt Cancer Center and the University of South Florida could create turning points.
Ocala.com - Jan. 13
Cure on Wheels, the fourth annual Capitol ride in support of Moffitt Cancer Center, will arrive in Ocala on Sunday.
ARRY-614 Shows Encouraging Results in Lower-Risk MDS Patients (ASH 2011)
The MDS Beacon - Jan. 13
Dr. Rami Komrokji of the Moffitt Cancer Center and Research Institute in Tampa, Florida, presented these results at the 2011 American Society of Hematology (ASH) meeting last month.
Banking pioneer Bob Samuels publishes his memoirs
Tampa Bay Times - Jan. 22
Today, Samuels talks about empowering men to take charge of their own health, said Rivers, a member of the research faculty for H. Lee Moffitt Cancer Center.
Peripheral Blood Stem Cells Increase Risk For Chronic Graft-Versus-Host Disease
Clinical Oncology News - January 2012, Volume 07:01
"We should perhaps ask ourselves whether the shift to greater use of PBSC over the past 10 years is justified in light of these results," said Claudio Anasetti, MD, chair of Blood and Marrow Transplant at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Fla., and the study's lead author.
Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.